Unusual Skin Carcinomas Induced by BRAF Inhibitor for Metastatic Melanoma: A Case Report

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 7

Abstract

The most frequently reported skin tumours during treatment with targeted therapies for BRAF (B type Rapidly Accelerated Fibrosarcoma kinase) mutated metastatic melanoma are squamous cell carcinomas (SCCs). Basal cell carcinomas (BCCs) have been described in such setting, but no cases of multiple and recurring tumours have been reported so far. A patient with a history of chronic sun exposure and more than 10 BCCs removed since 1998 started treatment with vemurafenib for BRAF mutated metastatic melanoma. Therapy was complicated by sporadic episodes of atrial fibrillation and by the development of recurrent, multiple and diffuse BCCs. So, vemurafenib was discontinued and dabrafenib and trametinib were started. Since then, only four BCCs occurred in the patient. Histopathological re-examination showed that most BCCs occurred under vemurafenib presented with squamous features. Such characteristic was significantly less evident before therapy start and in lesions removed under treatment with dabrafenib and trametinib. BRAF inhibition (BRAFi) without MEK inhibition induces mitogen activated kinases overactivation, with consequent skin toxicity and acquired drug resistance. The BCCs removed from our patient showed squamous features, more evident during vemurafenib monotherapy. Both the switch from vemurafenib to dabrafenib and the addition of MEK inhibitor (MEKi) might have reduced the incidence of BCCs and their squamous differentiation.

Authors and Affiliations

Stefano Cavalieri, Lorenza Di Guard, Mara Cossa, Carolina Cimminiello, Michele Del Vecchio

Keywords

Related Articles

Sudden and Unexpected Deaths among Women of Reproductive age – Qualitative Analysis of Risk Factors

Introduction: Unnatural deaths in women of reproductive age (range 12-49 years) have a serious psychological and social impact on the family and community. Women of reproductive age comprise a vulnerable section of the s...

Effect of Atorvastatin on Serum Levels of Lipase and Amylase in Patients of Hyperlipidemia

ABSTRACT Introduction: Hyperlipidemia is quite prevalent all over the world. Statins, which is the most common group of drugs used in its treatment is generally well tolerated. Recently, several cases of pancreatitis hav...

Sclerosing Pneumocytoma of the Lung: A Case Report

Pulmonary Sclerosing Pneumocytoma (PSP) is a rare tumour of the lung and is always benign. Diagnosis is made incidentally following chest X-ray or chest CT scan performed for other clinical conditions. We report a case o...

Attenuation of Haemodynamic Parameters in Response to Pneumoperitoneum during Laparoscopic Cholecystectomy: A Randomized Controlled Trial Comparing Infusions of Propofol and Dexmedetomidine

Introduction: Effective control of sympathetic response to pneumoperitoneum is vital to avoid morbidity in patients undergoing laparoscopic surgeries. This control must be achieved without any side effects of the drugs b...

Download PDF file
  • EP ID EP356374
  • DOI 10.7860/JCDR/2017/26881.10200
  • Views 67
  • Downloads 0

How To Cite

Stefano Cavalieri, Lorenza Di Guard, Mara Cossa, Carolina Cimminiello, Michele Del Vecchio (2017). Unusual Skin Carcinomas Induced by BRAF Inhibitor for Metastatic Melanoma: A Case Report. Journal of Clinical and Diagnostic Research, 11(7), 6-8. https://europub.co.uk/articles/-A-356374